In Short:
Aurobindo Pharma’s subsidiary TheraNym signed a deal with CuraTeQ and MSD for contract manufacturing of biologicals. TheraNym will build and operate the manufacturing facility in Telangana, supplying products to MSD. Aurobindo Pharma announced the development to BSE, reporting a 79% increase in Q4 PAT to ₹909 crore.
Exciting Partnership Announcement: TheraNym, CuraTeQ, and MSD Join Forces!
Guess what? TheraNym, which is a super cool subsidiary of Aurobindo Pharma, has teamed up with CuraTeQ and MSD to make some big moves in the world of contract manufacturing operations (CMO) for biologicals! How awesome is that?
TheraNym will be taking charge of building the manufacturing facility, producing the products, and then supplying them to MSD. And here’s the best part – the facility will be located in the scenic village of Borapatla in the Medak District of Telangana. How picturesque!
Key Highlights:
- Companies Involved: TheraNym, Aurobindo Pharma, CuraTeQ, MSD
- Agreement Type: Master Service Agreement (MSA)
- Location: Borapatla village, Hathnoora Mandal, Medak District, Telangana
And the cherry on top? Aurobindo Pharma, which is based in Hyderabad, was kind enough to share this exciting news with the Bombay Stock Exchange (BSE) on a bright Friday morning. It’s all happening, folks!
